Journal Article

Integrated single-cell and epigenomic analysis reveals cellular specificity of CYP2E1 in human alcohol-related liver disease

Get access
Toxicological Sciences, Volume 209, Issue 10, October 2026, kfag128, https://doi.org/10.1093/toxsci/kfag128
Published:
21 September 2026
Article history
Published:
21 September 2026
Corrected and typeset:
08 October 2026

Abstract

Cytochrome P450 2E1 (CYP2E1) is a key hepatic xenobiotic metabolizing enzyme classically localized to pericentral hepatocytes. However, its cellular specificity and regulatory landscape in human alcohol-related liver disease (ALD) remain incompletely defined. We aimed to delineate the spatial, cellular, and epigenetic determinants of CYP2E1 expression in health and in ALD. We integrated cross-species immunohistochemistry (human, mouse, rat, pig) with bulk RNA sequencing (human), single-cell RNA sequencing, and paired single-nucleus RNA and ATAC sequencing. Healthy controls and patients with ALD, including alcoholic hepatitis and cirrhosis, were analyzed to define CYP2E1 localization, zonation, and regulatory features across hepatocyte and non-parenchymal cell (NPC) populations. In healthy liver, CYP2E1 protein and transcript expression were predominantly localized to zone 3 hepatocytes across species and platforms. Apparent CYP2E1 signals in NPC populations were not accompanied by CYP2E1-linked chromatin accessibility and were consistent with hepatocyte-derived ambient RNA or technical contamination rather than bona fide NPC expression. In human ALD, CYP2E1 expression is reduced in alcoholic hepatitis and cirrhosis, particularly in the pericentral compartment, and is associated with increased AST levels and impaired metabolic zonation. These findings contrast with ethanol-induced CYP2E1 upregulation during active exposure and suggest that advanced ALD is characterized by loss of CYP2E1 expression linked to hepatocyte dysfunction. CYP2E1 is a predominantly hepatocytic enzyme that, in the healthy liver, exhibits strong pericentral enrichment. In chronic ALD, CYP2E1 expression appears to reflect pericentral hepatocyte integrity rather than ethanol responsiveness, highlighting the importance of rigorous cell-type validation in liver disease studies.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
You do not currently have access to this article.

Supplementary data

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period